Better Engineered
Solutions
-
Pharmaceutical
Agile and responsive, we continuously adapt to meet the evolving needs of the biotechnology and pharmaceutical industries
What sets us apart is that we always keep in the mind the people who rely on the products we make possible.
Pharmaceutical
Amidst the rapidly changing and competitive landscape of the life sciences sector, DPS is helping clients overcome challenges. We recognise that what works today may not be right tomorrow. That’s why one of our core strengths is our ability to adapt to regulatory changes and operational risk environments, and to deliver the highly specialized skills needed to deliver a successful project.
We have been designing and engineering sophisticated manufacturing facilities for over 40 years to the highest safety standards—from programming or early concept development stages through to the commissioning phase.
What sets us apart is that we always keep in the mind the people who rely on the products we make possible.
-
BMS, Hydrogenation Facility
DPS executed full EPCMV project services to deliver a cGMP upgrade to an existing Buss loop technology based Hydrogenation facility in the heart of the BMS facility in Swords.
-
Confidential Client, New Production Facility
DPS is implementing new production units in an existing and unused building, in partnership with Talboom
-
GSK, New Manufacturing Building
Green field cGMP BSL-3 vaccine manufacturing facility. At the end of the detailed design phase, GSK decided to build an integrated team for the Construction and Commissioning phase
-
GSK, Revamping Of A Production Area
Revamping of 1 500 m2 of classified areas dedicated to vials and syringes filling activities in the Building W16 in Wavre.
-
Janssen Biologics, Single Use Cell Culture Facility
DPS executed the full project engineering design for a new single use Cell Culture Suite at Janssen Biologics site in Cork, Ireland.
-
MSD, Sterile Manufacturing Facility Upgrade
DPS secured the Concept Study/Basis of Design Studies, Detailed Design and Qualification for the OPS1 Facility upgrade.
-
MSD, New Vaccines Fill Finish Facility
DPS successfully secured the C&Q client led team for the €220m Greenfield vaccines facility at MSD, Carlow, Ireland.
-
MSD, Tissue Culture Boxmeer Expansion
This project allows MSD to expand the Tissue Culture production facility for their Vaccine production operations in Boxmeer the Netherlands.
-
Pfizer, Multi-product Kilo Scale API Facility
DPS was awarded the complete architectural and engineering design for a New Products Facility (NPI) at Pfizer, Ringaskiddy site in Cork, Ireland.
-
Pfizer, New Sterile Vaccine Fill Finish Facility
DPS executed engineering, design and procurement for a new 5,000 sq.m vial fill finish facility at Pfizer Puurs, Belgium.
-
Pfizer, Sterile Manufacturing Facility, Site Master Planning, Spain
DPS were engaged to carry out a Site Master Plan and Feasibility Study for the Pfizer Algete site in Spain for a future sterile manufacturing expansion for a range of product formats;
-
Sanofi (Genzyme) 31NYA Pilot Plant, MA
Genzyme Biologics R&D is developing an integrated continuous bioprocessing platform for recombinant therapeutic proteins.
-
UMass MAB, Laboratory, Development and Early Phase Cell Culture Manufacturing Facility, MA
DPS provided full multidisciplinary A/E design for a new, 32,000 sq. ft. biopharmaceutical facility. The greenfield facility in Dartmouth MA, is the anchor tenant of a planned 300-acre biotechnology park.
Project Profiles
DPS Group is a global consulting, engineering and construction management company, serving high-tech industries around the world.
